Literature DB >> 21385848

Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function.

Isabelle Dunand-Sauthier1, Marie-Laure Santiago-Raber, Leonardo Capponi, Charles E Vejnar, Olivier Schaad, Magali Irla, Queralt Seguín-Estévez, Patrick Descombes, Evgeny M Zdobnov, Hans Acha-Orbea, Walter Reith.   

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate target mRNAs by binding to their 3' untranslated regions. There is growing evidence that microRNA-155 (miR155) modulates gene expression in various cell types of the immune system and is a prominent player in the regulation of innate and adaptive immune responses. To define the role of miR155 in dendritic cells (DCs) we performed a detailed analysis of its expression and function in human and mouse DCs. A strong increase in miR155 expression was found to be a general and evolutionarily conserved feature associated with the activation of DCs by diverse maturation stimuli in all DC subtypes tested. Analysis of miR155-deficient DCs demonstrated that miR155 induction is required for efficient DC maturation and is critical for the ability of DCs to promote antigen-specific T-cell activation. Expression-profiling studies performed with miR155(-/-) DCs and DCs overexpressing miR155, combined with functional assays, revealed that the mRNA encoding the transcription factor c-Fos is a direct target of miR155. Finally, all of the phenotypic and functional defects exhibited by miR155(-/-) DCs could be reproduced by deregulated c-Fos expression. These results indicate that silencing of c-Fos expression by miR155 is a conserved process that is required for DC maturation and function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385848     DOI: 10.1182/blood-2010-09-308064

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  70 in total

Review 1.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 2.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

Review 3.  MicroRNA-155: A Master Regulator of Inflammation.

Authors:  Guruswamy Mahesh; Roopa Biswas
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

Review 4.  Tumor-Derived Exosomes and Their Role in Cancer Progression.

Authors:  Theresa L Whiteside
Journal:  Adv Clin Chem       Date:  2016-04-07       Impact factor: 5.394

Review 5.  Exosomes and tumor-mediated immune suppression.

Authors:  Theresa L Whiteside
Journal:  J Clin Invest       Date:  2016-02-29       Impact factor: 14.808

6.  The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis.

Authors:  Takashi Tomiyama; Guo-Xiang Yang; Ming Zhao; Weici Zhang; Hajime Tanaka; Jing Wang; Patrick Sc Leung; Kazuichi Okazaki; Xiao-Song He; Qianjin Lu; Ross L Coppel; Christopher L Bowlus; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

7.  Rat mir-155 generated from the lncRNA Bic is 'hidden' in the alternate genomic assembly and reveals the existence of novel mammalian miRNAs and clusters.

Authors:  Paolo Uva; Letizia Da Sacco; Manuela Del Cornò; Antonella Baldassarre; Paola Sestili; Massimiliano Orsini; Alessia Palma; Sandra Gessani; Andrea Masotti
Journal:  RNA       Date:  2013-01-17       Impact factor: 4.942

Review 8.  Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function.

Authors:  Siambi Kikete; Xiaoqian Chu; Li Wang; Yuhong Bian
Journal:  Cytotechnology       Date:  2016-05-18       Impact factor: 2.058

Review 9.  Mini but mighty: microRNAs in the pathobiology of periodontal disease.

Authors:  Moritz Kebschull; Panos N Papapanou
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

10.  Cutting Edge: EZH2 Promotes Osteoclastogenesis by Epigenetic Silencing of the Negative Regulator IRF8.

Authors:  Celestia Fang; Yu Qiao; Kyung-Hyun Park-Min; Lionel B Ivashkiv; Se Hwan Mun; Min Joon Lee; Koichi Murata; Seyeon Bae; Baohong Zhao
Journal:  J Immunol       Date:  2016-04-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.